Deprescribing medicines in an intensive care unit of a university hospital from Ceará
Objectives: To evaluate the pharmaceutical deprescription recommendations made to patients hospitalized in an adult clinical Intensive Care Unit (ICU). Methods: This is a cross-sectional, descriptive, and quantitative study developed with pharmaceutical recommendations for drug deprescription, in the adult ICU of a university hospital in Fortaleza - CE, from 2017 to 2018. Data from patients and recommendations were collected from patient records. The acceptability of the recommendations was measured from the visualization of the suggested alteration in 24 hours. The drugs included in the recommendations were categorized according to the Anatomical Therapeutic Chemical (ATC) and Potentially Dangerous Drug (MPP) classifications. The data were compiled and analyzed using the Microsoft Office Excel® 2013 software. Results: A total of 388 recommendations were made for the non-prescription of medications to 210 adult patients who were mostly male (58%) and with a mean age of 56 years. ± 16.8. The acceptability of the recommendations was 93.3% (n=362) and the average number of medications not prescribed per patient was 1.7 ± 0.7, all of which were abruptly discontinued. Problems related to deprescription were mainly prescription of unnecessary drugs (77.6%) contraindicated drugs (8.0%) and therapeutic duplicity (5.1%). The most frequent therapeutic classes are antibacterials for systemic use (11.3%), ophthalmic (20.8%) and medicines for functional gastrointestinal disorders (9.5%). The main drugs not prescribed were hypromellose eye drops + dextran (9.6%), bromopride (6.9%) and injectable potassium chloride (5.8%), the latter being considered an MPP. The class most associated with non-acceptance of deprescription other than corticosteroids is systemic use (23.1%). Conclusion: This study showed a high level of acceptance of deprescription recommendations, especially among antibacterials for systemic use. Injectable potassium chloride, considered an MPP, ranked third overall in terms of non-prescription. Future studies should evaluate the impact of deprescription recommendations on morbidity and mortality in the ICU and on the reduction of hospital costs.
Cullen DJ, Sweitzer BJ, Bates DW, Burdick E, Edmondson A, Leape LL. Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units. Crit Care Med. 1997;25(8):1289-1297.
Cardinal LSM, Matos VTG, Resende GMS, et al. Characterization of drug prescriptions in an adult intensive care unit. Rev Bras Ter Intensiva. 2012; 24(2):151-6.
Ohta Y, Sakuma M, Koike K, et al. Influence of adverse drug events on morbidity and mortality in intensive care units: the JADE study. Int J Qual Health Care. 2014;26(6):573-8. doi: 10.1093/intqhc/mzu081.
Escrivá Gracia J, Brage Serrano R, Fernández Garrido J. Medication errors and drug knowledge gaps among critical-care nurses: a mixed multi-method study. BMC Health Serv Res. 2019;19(1):640. doi: 10.1186/s12913-019-4481-7.
Stollings JL, Bloom SL, Wang L, et al. Critical Care Pharmacists and Medication Management in an ICU Recovery Center. Ann Pharmacother. 2018;52(8):713-23. doi: 10.1177/1060028018759343.
Pichala PT, Kumar BM, Zachariah S, et al. An interventional study on intensive care unit drug therapy assessment in a rural district hospital in India. J Basic Clin Pharm. 2013;4(3):64-7. doi: 10.4103/0976-0105.118801.
Gracia JE, Sanz AA, Serrano RB, et al. Medication errors and risk areas in a critical care unit. J Adv Nurs. 2021;77(1):286-95. doi: 10.1111/jan.14612.
Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827-34. doi: 10.1001/jamainternmed.2015.0324.
Thillainadesan J, Gnjidic D, Gree S, et al. Impact of Deprescribing Interventions in Older Hospitalised Patients on Prescribing and Clinical Outcomes: A Systematic Review of Randomised Trials. Drugs aging. 2018; 35:303-19. doi: 10.1007/s40266-018-0536-4.
Zimmerman KM, Linsky AM. A narrative review of updates in deprescribing research. J Am Geriatr Soc. 2021;69(9):2619-24. doi: 10.1111/jgs.17273.
McCarthy M, Mak S, Kaufmann CN, et al. Care coordination needs for deprescribing benzodiazepines and benzodiazepine receptor agonists. Res Social Adm Pharm. 2022;18(4):2691-4. doi: 10.1016/j.sapharm.2021.06.025.
Mehta N, Martinez GF, Kamen C, et al. Proton Pump Inhibitors in the Elderly Hospitalized Patient: Evaluating Appropriate Use and Deprescribing. J Pharm Technol. 2020;36(2):54-60. doi: 10.1177/8755122519894953.
Krishnaswami A, Steinman MA, Goyal P, et al. Geriatric Cardiology Section Leadership Council, American College of Cardiology. Deprescribing in Older Adults With Cardiovascular Disease. J Am Coll Cardiol. 2019;73(20):2584-95. doi: 10.1016/j.jacc.2019.03.467.
Bjerre LM, Farrell B, Hogel M, et al. Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: Evidence-based clinical practice guideline. Can Fam Physician. 2018;64(1):17-27.
Oktora MP, Kerr KP, Hak E, et al. Rates, determinants and success of implementing deprescribing in people with type 2 diabetes: A scoping review. Diabet Med. 2021;38(2):e14408. doi: 10.1111/dme.14408.
Dills H, Shah K, Messinger-Rapport B, et al. Deprescribing Medications for Chronic Diseases Management in Primary Care Settings: A Systematic Review of Randomized Controlled Trials. J Am Med Dir Assoc. 2018;19(11):923-35.e2. doi: 10.1016/j.jamda.2018.06.021.
Farrel B, Tsang C, Raman-Wilms L, et al. What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process. PLoS One. 2015;10(4):1-16. doi: 10.1016/j.jamda.2018.06.021
Campbell NL, Perkins AJ, Khan BA, et al. Deprescribing in the Pharmacologic Management of Delirium: A Randomized Trial in the Intensive Care Unit. J Am Geriatr Soc. 2019;67(4):695-702. doi: 10.1111/jgs.15751.
Peterson GM, Naunton M, Deeks LS, et al. Practice pharmacists and the opportunity to support general practitioners in C.M. J Pharm Pract Res. 2018;48(2): 183-5. doi: 10.1002/jppr.1427.
Segundo Consenso de Granada sobre Problemas Relacionados con Medicamentos. Ars Pharm [Internet]. 20 de junio de 2002. Accessed Jun 11, 2022. https://revistaseug.ugr.es/index.php/ars/article/view/5689.
World Health Organization (WHO). The anatomical therapeutic chemical classification system with defined daily doses (ATC/DDD). Norway: WHO. 2006. Accessed Jan 11, 2022. https://www.whocc .no/atc_ddd_index/.
Instituto para Práticas Seguras no Uso de Medicamentos. Medicamentos Potencialmente Perigosos de Uso Hospitalar e Ambulatorial - Listas Atualizadas 2015. Boletim ISMP Brasil. 2015; 4(3). Disponível em: <http://www.ismp-brasil.org/site/wp-content/uploads/2015/12/V4N3.pdf>. Accessed 12 dic 2021.
Silva RSC, Gimenes FRE, Mantilla NPM, et al. Risk for corneal injury in intensive care unit patients: A cohort study. Intensive Crit Care Nurs. 2021;64:103017. doi: 10.1016/j.iccn.2021.103017.
Barros JR, Lobo IMF, Soares FM, et al. Fatores associados à diarreia em uma unidade de terapia intensiva: estudo de coorte. Nutr. clín. diet. hosp. 2018; 38(2):127-32 doi: 10.12873/382rodrigues.
Pearson DJ, Sharma A, Lospinoso JA, Morris MJ, McCann ET. Effects of Electrolyte Replacement Protocol Implementation in a Medical Intensive Care Unit. J Intensive Care Med. 2018;33(10):574-581. doi: 10.1177/0885066616679593.
Lamontagne F, Rochwerg B, Lytvyn L, et al. Corticosteroid therapy for sepsis: a clinical practice guideline. BMJ. 2018;362:k3284. doi: 10.1136/bmj.k3284.
Rodrigues AN, Fragoso LV, Beserra FM, et al. Determining impacts and factors in ventilator-associated pneumonia bundle. Rev Bras Enferm. 2016;69(6):1108-14. doi: 10.1590/0034-7167-2016-0253.
Marik PE, Khangoora V, Rivera R, et al. Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study. Chest. 2017;151(6):1229-38. doi: 10.1016/j.chest.2016.11.036.
Rice LB. Antimicrobial Stewardship and Antimicrobial Resistance. Med Clin North Am. 2018;102(5):805-18. doi: 10.1016/j.mcna.2018.04.004.
Bruniera FR, Ferreira FM, Saviolli LR, et al. The use of vancomycin with its therapeutic and adverse effects: a review. Eur Rev Med Pharmacol Sci. 2015;19(4):694-700.
Lindner G, Funk GC. Hypernatremia in critically ill patients. J Crit Care. 2013;28(2):216.e11-20. doi: 10.1016/j.jcrc.2012.05.001.
Wijdicks EFM. Lactulose: A Simple Sugar in a Complex Encephalopathy.Neurocrit Care. 2018;28(2):154-6. doi: 10.1007/s12028-017-0494-4.
Batassini É, Beghetto MG. Constipation in a cohort prospective in adult critically ill patients: How much occurs and why? Enferm Intensiva (Engl Ed). 2019;30(3):127-34. doi: 10.1016/j.enfi.2018.05.001.
Boonyawat K, Crowther MA. Venous thromboembolism prophylaxis in critically ill patients. Semin Thromb Hemost. 2015;41(1):68-74. doi: 10.1055/s-0034-1398386.
Gillmann HJ, Reichart J, Leffler A, et al. The antipyretic effectiveness of dipyrone in the intensive care unit: A retrospective cohort study. PLoS One. 2022;17(3):e0264440. doi: 10.1371/journal.pone.0264440.
Madsen KR, Lorentzen K, Clausen N, et al. Danish Society of Intensive Care Medicine; Danish Society of Anesthesiology and Intensive Care Medicine. Guideline for stress ulcer prophylaxis in the intensive care unit. Dan Med J. 2014;61(3):C4811.
Baldoni A, Zadra P, Vilar L, et al. Elaboração E validação do protocol de desprescrição do clonazepam em idosos. Rev Bras Med Fam 2020;15:2105. doi: 10.5712/rbmfc15(42)2105.
Motter FR, Hilmer SN, Paniz VMV. Pain and inflammation management in older adults: a Brazilian consensus of potentially inappropriate medication and their alternative therapies. Front Pharmacol 2019;10:1408. doi: 10.3389/fphar.2019.01408.
Lee H, Ryu K, Sohn Y, et al. Impact on patient outcomes of pharmacist participation in multidisciplinary critical care teams: a systematic review and meta-analysis. Crit Care Med. 2019;47(9):1243-1250. doi: 10.1097/CCM.0000000000003830.
Martins RR, Silva LT, Lopes FM. Impact of medication therapy management on pharmacotherapy safety in an intensive care unit. Int J Clin Pharm. 2019;41(1):179-188. doi: 10.1007/s11096-018-0763-0.
Krzyzaniak N, Bajorek B. A global perspective of the roles of the pharmacist in the NICU. Int J Pharm Pract. 2017;25(2):107-120. doi: 10.1111/ijpp.12284.
Chiang LH, Huang YL, Tsai TC. Clinical pharmacy interventions in intensive care unit patients. J Clin Pharm Ther. 2020;00:1–6. doi: 10.1111/jcpt.13265.
Fideles GMA, Alcântara-Neto JM, Júnior ARP, et al. Recomendações farmacêuticas em unidade de terapia intensiva: três anos de atividades clínicas. Rev Bras Ter Intensiva. 2015;27(2):149-54. doi: 10.5935/0103-507X.20150026
Rose O, Mennemann H, John C, et al. Priority Setting and Influential Factors on Acceptance of Pharmaceutical Recommendations in Collaborative Medication Reviews in an Ambulatory Care Setting – Analysis of a Cluster Randomized Controlled Trial (WestGem-Study). PLoS ONE. 2016;11(6):e0156304. doi:10.1371/journal.pone.0156304.
Durand A, Gillibert A, Membre S, et al. Acceptance Factors for In-Hospital Pharmacist Interventions in Daily Practice: A Retrospective Study. Front. Pharmacol. 2022;13:811289. doi: 10.3389/fphar.2022.811289.
Tjia J, Velten SJ, Parsons C, et al. Studies to reduce unnecessary medication use in frail older adults: a systematic review. Drugs Aging. 2013;30(5):285-307. doi: 10.1007/s40266-013-0064-1.
Garin N, Sole N, Lucas B, et al. Drug related problems in clinical practice: a cross-sectional study on their prevalence, risk factors and associated pharmaceutical interventions. Sci Rep. 2021;11(1):883. doi: 10.1038/s41598-020-80560-2.
Lodise TP, Drusano GL. Pharmacokinetics and pharmacodynamics: optimal antimicrobial therapy in the intensive care unit. Crit Care Clin. 2011;27(1):1-18.
Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y. Corticosteroids for treating sepsis. Cochrane Database Syst Rev 2015;12:CD002243.
Annane D, Renault A, Brun-Buisson C, et al. Hydrocortisone plus Fludrocortisone for Adults with Septic Shock. N Engl J Med. 2018;378(9):809-18. doi: 10.1056/NEJMoa1705716.
Amin KA, Belsito DV. The aetiology of eyelid dermatitis: a 10-year retrospective analysis. Contact Dermatitis. 2006;55(5):280-5. doi: 10.1111/j.1600-0536.2006.00927.x.
Cajanding JMR. Administering and monitoring high-alert medications in acute care. Nursing Standard. 2017;31(47):42–52. doi: 10.7748/ns.2017.e10849
Cornuault L, Mouchel V, Phan Thi TT, et al. Identification of variables influencing pharmaceutical interventions to improve medication review efficiency. Int J Clin Pharm. 2018;40(5):1175-79. doi: 10.1007/s11096-018-0668-y.
How to Cite
Copyright (c) 2022 Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The authors hereby transfer, assign, or otherwise convey to RBFHSS: (1) the right to grant permission to republish or reprint the stated material, in whole or in part, without a fee; (2) the right to print republish copies for free distribution or sale; and (3) the right to republish the stated material in any format (electronic or printed). In addition, the undersigned affirms that the article described above has not previously been published, in whole or part, is not subject to copyright or other rights except by the author(s), and has not been submitted for publication elsewhere, except as communicated in writing to RHFHSS with this document.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-NC-ND) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
This journal permits and encourages authors to post and archive the final pdf of the articles submitted to the journal on personal websites or institutional repositories after publication, while providing bibliographic details that credit its publication in this journal.